Biomarin Pharmaceutical News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

20.11.13	ATRC On The GO, BMRN Gets Panel's Nod, CLVS Opens Purse Strings, POZN Surges (RTTNews)
31.10.13	BioMarin Begins Phase 3 Trial Of BMN 673 For Metastatic GBRCA Breast Cancer (RTTNews)
24.10.13	BioMarin Pharma Q3 Loss Widens - Quick Facts (RTTNews)
15.10.13	Upcoming Financial Results Schedules, Clinical Studies and Trials, and New Appointments - Research Report on BioMarin, Alnylam, Aegerion, Omeros, and Tesaro (PR Newswire)
07.10.13	Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon (PR Newswire)
03.10.13	Critical Alerts For Boeing, Medtronic, Darden, BioMarin Pharmaceutical, and HollyFrontier Released By InvestorsObserver (PR Newswire)
30.09.13	Today's Research: Astex Pharma Inc., Delcath Systems Inc., BioMarin Pharma Inc., and Akorn Inc. (PR Newswire)
29.09.13	BioMarin Pharma Issues Updated Phase 1/2 Data On BMN 673 In Breast Cancer (RTTNews)
23.09.13	BioMarin Doses First Patient In Phase 1/2 Trial For BMN 190 - Quick Facts (RTTNews)
19.09.13	Pre-market Movers For Sept 19 (A, RAD, BMRN, PIR, SSNC, PGRX, CAG) (RTTNews)
09.09.13	Appointments, Successful Clinical Trials, Mergers, and New Contracts Boost Growth - Research Report on BioMarin, ARIAD, Bard, Rockwell Medical, and Health Net (PR Newswire)
03.09.13	Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation (PR Newswire)
21.08.13	Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc. (PR Newswire)
19.08.13	MNKD To Get Financing, PTIE, DRRX Vault, BMRN On Watch (RTTNews)
02.08.13	Expanding R&D Programs, Clinical Trials, Drug Applications and Acquisitions, Advancing to Help Patients with Unmet Medical Needs - Research Report on Questcor, BioMarin, Vanda, Illumina and Theravance (PR Newswire)
26.07.13	BioMarin Pharma Q2 Loss Narrows - Quick Facts (RTTNews)
12.09.08	William Blair & Company Initiates Coverage of BioMarin Pharmaceutical Inc. With Outperform Rating (Businesswire)
12.01.05	Medicis and BioMarin Reach Settlement (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	534.40	0.64 %	K V
Roche Hldg G	253.00	0.64 %	K V
Nestle	76.26	0.55 %	K V
Kuehne+Nagel Int	209.40	0.38 %	K V
Givaudan	3’890.00	0.18 %	K V
Swiss Life Hldg	717.80	-0.22 %	K V
Sika	227.50	-0.48 %	K V
ABB	49.30	-0.48 %	K V
Logitech Intl	71.60	-0.53 %	K V
UBS Group	27.54	-0.79 %	K V

mehr

16.09.24		NASDAQ Composite aktuell: NASDAQ Composite schlussendlich im Minus
16.09.24		NASDAQ-Handel So entwickelt sich der NASDAQ Composite am Nachmittag
16.09.24		Anleger in New York halten sich zurück: NASDAQ Composite am Montagmittag schwächer
16.09.24		Verluste in New York: NASDAQ Composite verliert zum Start
06.08.24		Freundlicher Handel in New York: NASDAQ Composite zum Handelsende im Plus
06.08.24		Freundlicher Handel: NASDAQ Composite am Nachmittag freundlich
06.08.24		Handel in New York: NASDAQ Composite mittags mit grünem Vorzeichen
06.08.24		Börse New York in Grün: NASDAQ Composite zum Start des Dienstagshandels in Grün